Figure 3.

Effects of Tocotrienol-Rich Fraction (TRF) supplementation on escape latencies across treatment groups throughout the 5 day acquisition phase. Data expressed as mean ± SD (n = 10). **P < 0.01 and ***P < 0.05 denotes significant difference from the control group.

Nagapan et al. BMC Neuroscience 2013 14:77   doi:10.1186/1471-2202-14-77
Download authors' original image